# SABR for T1-2a N1 NSCLC

> **NCT03321760** · PHASE2 · WITHDRAWN · sponsor: **Indiana University**

## Conditions studied

- Lung Cancer

## Interventions

- **RADIATION:** Stereotactic Ablative Radiation Therapy (SABR)

## Key facts

- **NCT ID:** NCT03321760
- **Lead sponsor:** Indiana University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2022-01-01
- **Primary completion:** 2025-12-31
- **Final completion:** 2027-12-31
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Decided not to open the study.
- **Last updated:** 2022-02-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03321760

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03321760, "SABR for T1-2a N1 NSCLC". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03321760. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*